These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2683026)

  • 1. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs.
    Lanza FL
    Scand J Gastroenterol Suppl; 1989; 163():24-31. PubMed ID: 2683026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The epidemiology of the gastroduodenal damage induced by aspirin and other nonsteroidal anti-inflammatory drugs].
    Dobrilla G; Benvenuti S; de Guelmi A
    Recenti Prog Med; 1997 May; 88(5):202-11. PubMed ID: 9244954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury.
    Donnelly MT; Goddard AF; Filipowicz B; Morant SV; Shield MJ; Hawkey CJ
    Aliment Pharmacol Ther; 2000 May; 14(5):529-34. PubMed ID: 10792114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
    Iijima K; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSAID-induced gastric mucosal damage.
    Semble EL; Wu WC
    Am Fam Physician; 1987 Jun; 35(6):101-8. PubMed ID: 3332745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
    Larkai EN; Smith JL; Lidsky MD; Graham DY
    Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
    Lanza FL; Codispoti JR; Nelson EB
    Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin may or may not damage the gastric mucosa.
    Graham DY; Moon N
    Gastroenterology; 1999 Dec; 117(6):1505. PubMed ID: 10610340
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of gastric injury with enteric- versus nonenteric-coated aspirin.
    Banoob DW; McCloskey WW; Webster W
    Ann Pharmacother; 2002 Jan; 36(1):163-6. PubMed ID: 11816246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial].
    Ehrmann J; Procházka V; Konecný M; Spacek M; Urbánek K
    Vnitr Lek; 2007 Oct; 53(10):1024-8. PubMed ID: 18072422
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastric mucosal injury by nonsteroidal anti-inflammatory drugs is reduced by (R)-alpha-methylhistamine and its pro-drugs in the rat.
    Morini G; Grandi D; Krause M; Schunack W
    Inflamm Res; 1997 Mar; 46 Suppl 1():S101-2. PubMed ID: 9098786
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insight into the mechanisms of gastroduodenal injury induced by nonsteroidal anti-inflammatory drugs: practical implications.
    Kwiecień S; Magierowska K; Śliwowski Z; Wójcik D; Magierowski M; Brzozowski T
    Pol Arch Med Wewn; 2015; 125(3):191-8. PubMed ID: 25666703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions.
    Dammann HG; Burkhardt F; Wolf N
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1109-14. PubMed ID: 10468689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial.
    Laine L; Maller ES; Yu C; Quan H; Simon T
    Gastroenterology; 2004 Aug; 127(2):395-402. PubMed ID: 15300570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin, salicylate and gastrointestinal injury.
    Fernández AG; Salcedo C; Palacios JM
    Nat Med; 1995 Jul; 1(7):602-3. PubMed ID: 7585130
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
    Nema H; Kato M
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy.
    Blandizzi C; Tuccori M; Colucci R; Fornai M; Antonioli L; Ghisu N; Del Tacca M
    Pharmacol Res; 2009 Feb; 59(2):90-100. PubMed ID: 19073262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroduodenal mucosal damage with salsalate versus aspirin: results of experimental models and endoscopic studies in humans.
    Scheiman JM; Elta GH
    Semin Arthritis Rheum; 1990 Oct; 20(2):121-7. PubMed ID: 2123561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.